Rhinostop Double Help, spray 0.1 mg+5 mg/dose 15 ml

.

Indications

– Acute respiratory diseases with rhinitis phenomena;

– acute allergic rhinitis;

– vasomotor rhinitis;

– sinusitis;

– otitis media (as part of combined therapy to reduce nasopharyngeal mucosal edema);

– to facilitate rhinoscopy;

– to restore impaired nasal breathing after surgical interventions in the nasal cavity.

Active ingredient

Composition

Per 1 dose:

The active ingredients:

xylometazoline hydrochloride – 0.1 mg,

dexpanthenol – 5 mg.

Excipients: sodium citrate dihydrate – 0.509 mg, sodium chloride – 0.250 mg, hypromellose – 0.100 mg, benzalkonium chloride – 0.015 mg, citric acid monohydrate – 0.350 mg, purified water to 100 µl.

How to take, the dosage

Intranasally.

In adults and children over 6 years of age

When using the nasal spray, keep the bottle upright. The nasal passages must be cleaned before use.

At the time of injection, it is necessary to inhale lightly through the nose. One injection into each nasal passage up to 3-4 times a day.

The duration of therapy is 5-7 days.

Do not use for more than 7 days. The duration of use of the drug in children is determined after consultation with a physician.

Repeated use is possible only after a break of several days.

If after 5 days of treatment there is no improvement or if symptoms worsen or new symptoms develop, you should talk to your doctor. Use only with the directions, route of administration, and amount prescribed.

Interaction

The simultaneous use of MAO inhibitors and tricyclic antidepressants may increase the systemic effects.

If you are using any other medications (including over-the-counter medications) at the same time, consult a physician before use.

Special Instructions

The nasal passages should be cleaned before use.

Avoid getting the product in the eyes.

The drug should be used individually to avoid spread of infection. The duration of use of the drug in children is determined after consultation with a physician.

Patients with prolonged QT interval syndrome using xylometazoline may be at increased risk of serious ventricular arrhythmias.

Do not exceed the maximum timing and recommended doses when self-administering the drug. Consult a physician if there is no reduction or if symptoms become more severe.

The drug does not affect the ability to drive or operate machinery when used according to the directions for administration, but if any adverse reaction occurs, the patient should abstain from these activities.

Contraindications

Diabetes mellitus, pheochromocytoma, cardiovascular diseases (including coronary heart disease), hypersensitivity to the action of adrenergic drugs accompanied by insomnia, dizziness, arrhythmias, tremors, increased blood pressure.

If you have one or more of the above diseases and conditions, you should consult a doctor before starting this medicine.

Side effects

The undesired phenomena presented below are listed according to anatomophysiological classification and frequency of occurrence.

The frequency of occurrence is defined as follows: very common (with an incidence greater than 1/10), common (with an incidence of at least 1/100 but less than 1/10), infrequent (with an incidence of at least 1/1000 but less than 1/100), rare (with an incidence of at least 1/10000. but less than 1/1000), very rare (with an incidence of less than 1/10000), unknown (frequency based on available data is unknown).

Nervous system disorders:

Very rare: restlessness, insomnia, headache, fatigue (drowsiness), hallucinations (mostly in children).

Disorders of the cardiovascular system:

Rarely: palpitations, tachycardia, increased blood pressure.

Very rare: arrhythmia.

Respiratory system disorders:

Very rare: nasal mucosal edema, hypersecretion, nasal bleeding.

Prevalence unknown: burning and dryness of the nasal mucosa, sneezing.

Muscular system disorders:

Very rare: seizures (especially in children).

Immune system disorders:

Very rare: allergic reactions (angioedema, skin rash, itching).

If any of the side effects listed in the instructions worsen, or if you notice any other side effects not listed in the instructions, tell your doctor.

Overdose

In cases of overdose or accidental oral administration the following symptoms may occur: mydriasis, nausea, vomiting, cyanosis, fever, seizures, tachycardia, heart rhythm disorders, vascular failure, cardiac arrest, hypertension, pulmonary edema, respiratory depression, hallucinations.

Patients may also experience CNS depressive symptoms accompanied by drowsiness, decreased body temperature, bradycardia, shock, respiratory arrest and coma.

Treatment

The use of activated charcoal, gastric lavage, oxygen ventilation of the lungs. For reduction of arterial pressure, 5 mg of phentolamine in 0.9% sodium chloride solution by slow intravenous injection, or 100 mg of phentolamine by oral administration is prescribed. Vasoconstrictors are contraindicated. If necessary, antipyretics and anticonvulsants are used.

In case of overdose, seek medical attention.

Pregnancy use

The drug should not be used during pregnancy.

The drug is contraindicated while breastfeeding.

Consult your doctor before using if you are pregnant or think you may be pregnant, or if you are planning to become pregnant.

Similarities